Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study

BACKGROUND: Ketamine and its enantiomer esketamine represent promising new treatments for treatment-resistant depression (TRD). Esketamine induces acute, transient psychoactive effects. How patients perceive esketamine treatment, and which conditions facilitate optimal outcomes, remains poorly under...

Descripción completa

Detalles Bibliográficos
Autores principales: Breeksema, Joost J., Niemeijer, Alistair, Kuin, Bouwe, Veraart, Jolien, Kamphuis, Jeanine, Schimmel, Nina, van den Brink, Wim, Vermetten, Eric, Schoevers, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732097/
https://www.ncbi.nlm.nih.gov/pubmed/36506427
http://dx.doi.org/10.3389/fpsyt.2022.948115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732097/
https://www.ncbi.nlm.nih.gov/pubmed/36506427
http://dx.doi.org/10.3389/fpsyt.2022.948115

Ejemplares similares